Apothecary Pharma Llc: Apothecary Nad+ Injection 200 Mg/ml
Summary Apothecary Pharma LLC is recalling Apothecary NAD+ Injection 200 mg/mL in 6 mL vials nationwide because the company cannot confirm the product is sterile. This is a prescription medication that was distributed across all U.S. states and the District of Columbia.
- Recalling firm
- Apothecary Pharma LLC
- Product
- Apothecary NAD+ Injection 200 mg/mL, 6 mL Sterile Multi-Dose Vial, Rx Only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC, 27513, NDC 85091-011-06.
- Reason
- Lack of Assurance of Sterility
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-09-24
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide within the United States
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/09c1fb29-76d3-4683-871a-e393da69dd84